Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis
Authors:
- 18 May 2016
- journal article
- Published by Spandidos Publications in Biomedical Reports
- Vol. 5 (1) , 107-112
Abstract
The aim of the present study was to investigate the correlation between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis. A total of 30 infants with cholestasis and 20 healthy infants were included in the study. Biochemical assays based on the initial rate method and colorimetric assays were conducted to determine the levels of liver function markers in the serum [such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), direct bilirubin (DBIL), indirect bilirubin (IBIL), γ‑glutamyl transferase (γ‑GT), cholinesterase (CHE) and total bile acids (TBA)] and four serum biomarkers of liver fibrosis were measured using radioimmunoassays [hyaluronic acid (HA), procollagen type III (PCIII), laminin (LN) and collagen type IV (cIV)]. The serum levels of ALT, AST, TBIL, DBIL, IBIL, γ‑GT and TBA in the infants with cholestasis were significantly higher compared to the healthy infants (P<0.01); the serum levels of CHE in the infants with cholestasis were significantly lower compared to the healthy infants (P<0.01). The serum levels of HA, PCIII, and cIV in the infants with cholestasis were significantly higher compared to the healthy infants (P<0.01). Correlation analyses between liver function and the four biomarkers of liver fibrosis showed that HA was positively correlated with AST and γ‑GT (P<0.05) and negatively correlated with ALT, CHE and TBA (P<0.05). cIV was positively correlated with γ‑GT (P<0.05) and negatively correlated with CHE (P<0.05). In conclusion, statistically significant differences were identified for the liver function markers (ALT, AST, TBIL, DBIL, IBIL, γ‑GT and TBA) and the biomarkers HA, PCIII and cIV of liver fibrosis between infants with cholestasis and healthy infants. Thus, the serum levels of HA, cIV, γ‑GT and CHE are sensitive markers for cholestatic liver fibrosis in infants.Keywords
This publication has 11 references indexed in Scilit:
- The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid–regulating gene expression in rat liverNutrition Research, 2013
- A combination of mutations in AKR1D1 and SKIV2L in a family with severe infantile liver diseaseOrphanet Journal of Rare Diseases, 2013
- Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia majorArab Journal of Gastroenterology, 2012
- Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?Journal of Translational Medicine, 2012
- Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver diseaseTranslational Research, 2010
- Usefulness of Non-invasive Markers for Predicting Significant Fibrosis in Patients with Chronic Liver DiseaseJournal of Korean Medical Science, 2010
- A new splicing site mutation of the ABCB4 gene in intrahepatic cholestasis of pregnancy with raised serum γ-GTDigestive and Liver Disease, 2009
- Guideline for the Evaluation of Cholestatic Jaundice in Infants: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and NutritionJournal of Pediatric Gastroenterology and Nutrition, 2004
- AGA technical review on the evaluation of liver chemistry testsGastroenterology, 2002
- Genetic defects in hepatobiliary transportBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002